Perimeter Historical Income Statement

Stocks . Canada . 
Stock . Perimeter Medical Imaging
PINK Stock  CAD 0.46  0.01  2.13%   
Historical analysis of Perimeter Medical income statement accounts such as Interest Income of 7.1 K, Depreciation And Amortization of 1 M, Selling General Administrative of 5.7 M or Selling And Marketing Expenses of 3 M can show how well Perimeter Medical Imaging performed in making a profits. Evaluating Perimeter Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Perimeter Medical's future profits or losses.
Cash Flow   Balance Sheet     Income Statement
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Perimeter Medical Imaging latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Perimeter Medical Imaging is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Perimeter Medical Imaging. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

About Perimeter Income Statement Analysis

Perimeter Medical Imaging Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Perimeter Medical shareholders. The income statement also shows Perimeter investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Balance Sheet
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details

Perimeter Medical Income Statement Chart

At this time, Perimeter Medical's Net Interest Income is fairly stable compared to the past year. Depreciation And Amortization is likely to climb to about 1 M in 2025, whereas Other Operating Expenses is likely to drop slightly above 13.6 M in 2025.
Other Operating Expenses  Selling General Administrative  Selling And Marketing Expenses  Research Development  
Add Fundamental

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Perimeter Medical Imaging. It is also known as Perimeter Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Perimeter Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Perimeter Medical Imaging current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Perimeter Medical Imaging. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
At this time, Perimeter Medical's Net Interest Income is fairly stable compared to the past year. Depreciation And Amortization is likely to climb to about 1 M in 2025, whereas Other Operating Expenses is likely to drop slightly above 13.6 M in 2025.
 2024 2025 (projected)
Depreciation And Amortization954.1K1.0M
Interest Income9.0K7.1K

Perimeter Medical income statement Correlations

Other Operating Expenses
Ebit
Net Interest Income
Interest Income
Depreciation And Amortization
Selling General Administrative
Selling And Marketing Expenses
Gross Profit
Operating Income
Net Income From Continuing Ops
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Reconciled Depreciation
Income Before Tax
Total Other Income Expense Net
Net Income
Income Tax Expense
Other Operating Expenses
-0.950.930.960.82-0.640.94-0.56-0.83-0.620.88-0.820.710.950.8-0.750.24-0.53-0.3
Ebit
-0.95-0.94-0.9-0.860.67-0.890.630.90.7-0.930.89-0.79-0.9-0.830.81-0.220.60.26
Net Interest Income
0.93-0.940.970.85-0.640.92-0.53-0.85-0.630.93-0.840.720.910.84-0.770.23-0.52-0.35
Interest Income
0.96-0.90.970.8-0.590.93-0.46-0.77-0.550.87-0.760.640.930.79-0.690.24-0.45-0.37
Depreciation And Amortization
0.82-0.860.850.8-0.920.87-0.67-0.92-0.630.95-0.90.870.870.99-0.730.52-0.46-0.41
Selling General Administrative
-0.640.67-0.64-0.59-0.92-0.790.520.810.59-0.840.79-0.73-0.74-0.930.61-0.550.320.51
Selling And Marketing Expenses
0.94-0.890.920.930.87-0.79-0.49-0.87-0.70.93-0.860.690.970.87-0.770.27-0.49-0.45
Gross Profit
-0.560.63-0.53-0.46-0.670.52-0.490.80.7-0.670.81-0.94-0.67-0.550.78-0.070.83-0.37
Operating Income
-0.830.9-0.85-0.77-0.920.81-0.870.80.87-0.961.0-0.91-0.9-0.860.93-0.190.750.14
Net Income From Continuing Ops
-0.620.7-0.63-0.55-0.630.59-0.70.70.87-0.780.88-0.73-0.73-0.550.970.290.9-0.14
Research Development
0.88-0.930.930.870.95-0.840.93-0.67-0.96-0.78-0.950.860.930.92-0.870.25-0.63-0.3
Ebitda
-0.820.89-0.84-0.76-0.90.79-0.860.811.00.88-0.95-0.91-0.9-0.840.94-0.150.780.1
Cost Of Revenue
0.71-0.790.720.640.87-0.730.69-0.94-0.91-0.730.86-0.910.80.78-0.840.24-0.760.1
Total Operating Expenses
0.95-0.90.910.930.87-0.740.97-0.67-0.9-0.730.93-0.90.80.84-0.830.23-0.62-0.24
Reconciled Depreciation
0.8-0.830.840.790.99-0.930.87-0.55-0.86-0.550.92-0.840.780.84-0.640.6-0.33-0.55
Income Before Tax
-0.750.81-0.77-0.69-0.730.61-0.770.780.930.97-0.870.94-0.84-0.83-0.640.190.92-0.13
Total Other Income Expense Net
0.24-0.220.230.240.52-0.550.27-0.07-0.190.290.25-0.150.240.230.60.190.43-0.68
Net Income
-0.530.6-0.52-0.45-0.460.32-0.490.830.750.9-0.630.78-0.76-0.62-0.330.920.43-0.51
Income Tax Expense
-0.30.26-0.35-0.37-0.410.51-0.45-0.370.14-0.14-0.30.10.1-0.24-0.55-0.13-0.68-0.51
Click cells to compare fundamentals

Perimeter Medical Account Relationship Matchups

High Positive Relationship

Ebitda
+ 1.0
Operating Income
Reconciled Depreciation
+ 0.99
Depreciation And Amortization
Interest Income
+ 0.97
Net Interest Income
Total Operating Expenses
+ 0.97
Selling And Marketing Expenses
Income Before Tax
+ 0.97
Net Income From Continuing Ops
Interest Income
+ 0.96
Other Operating Expenses

High Negative Relationship

Research Development
- 0.96
Operating Income
Ebitda
- 0.95
Research Development
Ebit
- 0.95
Other Operating Expenses
Cost Of Revenue
- 0.94
Gross Profit
Net Interest Income
- 0.94
Ebit
Reconciled Depreciation
- 0.93
Selling General Administrative

Perimeter Medical income statement Accounts

202020212022202320242025 (projected)
Interest Expense117.0K110.3K104.9K144.4K166.1K116.0K
Other Operating Expenses10.1M16.1M16.3M22.8M26.2M13.6M
Ebit(11.7M)(16.0M)(16.1M)(22.3M)(20.0M)(21.0M)
Net Interest Income(1.7M)(80.3K)(104.9K)581.1K668.3K701.7K
Depreciation And Amortization47.6K93.8K800.9K829.7K954.1K1.0M
Selling General Administrative8.8M7.9M5.4M6.1M5.5M5.7M
Selling And Marketing Expenses122.9K3.7M4.8M5.0M5.7M3.0M
Gross Profit(47.6K)5.0K100.6K(357.8K)(322.1K)(306.0K)
Operating Income(11.7M)(16.0M)(16.1M)(22.3M)(20.0M)(21.0M)
Net Income From Continuing Ops(7.9M)(13.3M)(9.9M)(14.0M)(12.6M)(13.3M)
Research Development468.3K4.5M5.5M7.0M8.0M8.4M
Ebitda(11.6M)(16.0M)(15.3M)(21.4M)(19.3M)(20.3M)
Cost Of Revenue47.6K6.3K32.1K902.5K1.0M1.1M
Total Operating Expenses10.1M16.1M16.2M21.9M25.2M16.0M
Reconciled Depreciation47.6K74.8K800.9K614.7K706.9K742.3K
Income Before Tax(7.9M)(16.7M)(9.9M)(18.9M)(17.0M)(17.9M)
Total Other Income Expense Net3.8M(603.4K)6.2M3.3M3.8M3.4M
Net Income(8.0M)(16.8M)(3.6M)(18.9M)(17.0M)(17.9M)
Income Tax Expense117.0K110.3K(6.3M)2.01.81.89

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Perimeter Stock Analysis

When running Perimeter Medical's price analysis, check to measure Perimeter Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perimeter Medical is operating at the current time. Most of Perimeter Medical's value examination focuses on studying past and present price action to predict the probability of Perimeter Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perimeter Medical's price. Additionally, you may evaluate how the addition of Perimeter Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY